Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Harvey · SciRah

Researcher profile · Semantic Scholar

H. Harvey

Share profile

H. Harvey — researcher profile on SciRah

h-index: 37
Works: 136
Citations: 5,744

Most-cited papers

Ovarian cancer: screening, treatment, and followup.
V. Seltzer, B. Drukker, B. Gillespie, Lynn M. Gossfeld +47 more
1995NIH consensus statement574 citations
Semantic Scholar
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
M. Yin, M. Joshi, R. Meijer, M. Glantz +6 more
2016The Oncologist455 citations Open access
Semantic Scholar
Endocrine treatment of breast cancer in women.
R. Santen, A. Manni, H. Harvey, C. Redmond
1990Endocrine reviews416 citations
Semantic Scholar
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
K. Leitzel, Y. Teramoto, K. Konrad, V. Chinchilli +5 more
1995Journal of Clinical Oncology325 citations
Semantic Scholar
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer.
A. Lipton, S. Ali, K. Leitzel, L. Demers +8 more
2002Journal of Clinical Oncology296 citations
Semantic Scholar
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
Hong-Yan Jia, C. Truica, Bin Wang, Yan-Hong Wang +4 more
2017Drug resistance updates188 citations
Semantic Scholar
Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.
B. Weber, C. Vogel, S. Jones, H. Harvey +3 more
1995Journal of Clinical Oncology186 citations
Semantic Scholar
Use of aromatase inhibitors in breast carcinoma.
R. Santen, H. Harvey
1999Endocrine-Related Cancer180 citations Open access
Semantic Scholar
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
Rakesh Kumar, M. Mandal, A. Lipton, H. Harvey +1 more
1996Clinical Cancer Research160 citations
Semantic Scholar
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen.
A. Lipton, S. Ali, K. Leitzel, L. Demers +5 more
2003Journal of Clinical Oncology141 citations
Semantic Scholar
Unmet needs of persons with cancer in pennsylvania during the period of terminal care
P. Houts, H. Harvey, A. Hartz, M. Bartholomew +4 more
1988Cancer112 citations Open access
Semantic Scholar
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
A. Manni, M. Bartholomew, R. Caplan, A. Boucher +6 more
1988Journal of Clinical Oncology109 citations
Semantic Scholar
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer
G. Somlo, P. Frankel, B. Arun, Cynthia X. Ma +23 more
2017Clinical Cancer Research94 citations Open access
Semantic Scholar
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
Suhail M. Ali, K. Leitzel, V. Chinchilli, L. Engle +5 more
2002Clinical Chemistry92 citations
Semantic Scholar
Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites
W. El-Deiry, Namrata Vijayvergia, J. Xiu, Angelique Scicchitano +5 more
2015Cancer Biology & Therapy87 citations Open access
Semantic Scholar
The impact of 2D versus 3D quantitation of tumor bulk determination on current methods of assessing response to treatment.
K. Hopper, Claudia J. Kasales, K. Eggli, T. R. TenHave +8 more
1996Journal of computer assisted tomography81 citations
Semantic Scholar
Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
A. Lipton, C. Campbell-Baird, L. Witters, H. Harvey +1 more
2010Journal of Clinical Gastroenterology67 citations
Semantic Scholar
The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
L. Demers, J. Melby, T. Wilson, A. Lipton +2 more
1990Journal of Clinical Endocrinology and Metabolism64 citations
Semantic Scholar
Toremifene: an evaluation of its safety profile.
H. Harvey, M. Kimura, A. Hajba
2006Breast60 citations
Semantic Scholar
Treatment of advanced pancreatic cancer with opioid growth factor: phase I
Jill P. Smith, R. Conter, Sandra I. Bingaman, H. Harvey +6 more
2004Anti-Cancer Drugs60 citations
Semantic Scholar
Metastatic breast cancer: overview of treatment.
Suhail M. Ali, H. Harvey, A. Lipton
2003Clinical Orthopaedics and Related Research55 citations
Semantic Scholar
Primary female breast sarcoma: clinicopathological features, treatment and prognosis
M. Yin, H. Mackley, J. Drabick, H. Harvey
2016Scientific Reports53 citations Open access
Semantic Scholar
Elevated plasma platelet-derived growth factor B-chain levels in cancer patients.
K. Leitzel, W. Bryce, J. Tomita, G. Manderino +7 more
1991Cancer Research49 citations
Semantic Scholar
Biology of bone metastases: causes and consequences.
H. Harvey, Leah von Reyn Cream
2007Clinical Breast Cancer42 citations
Semantic Scholar
Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens.
C. L. Kline, Angelique Schiccitano, Jun-Jia Zhu, Cheryl Beachler +10 more
2014Clinical colorectal cancer38 citations
Semantic Scholar
Emerging role of aromatase inhibitors in the treatment of breast cancer.
H. Harvey
1998Oncology34 citations
Semantic Scholar
Predictors of Grief Among Spouses of Deceased Cancer Patients
P. Houts, A. Lipton, H. Harvey, M. Simmonds +1 more
198931 citations
Semantic Scholar
Aromatase inhibitor development for treatment of breast cancer
S. Masamura, H. Adlercreutz, H. Harvey, A. Lipton +3 more
2004Breast Cancer Research and Treatment28 citations
Semantic Scholar
INITIAL CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENT QUALITY OF LIFE
H. Harvey
199828 citations
Semantic Scholar
Phase I study combining tumor necrosis factor with interferon-α and interleukin-2
E. Eskander, H. Harvey, E. Givant, A. Lipton
199728 citations
Semantic Scholar
Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series
Shanthi Sivendran, H. Harvey, A. Lipton, J. Drabick
2011International journal of hematology27 citations
Semantic Scholar
Growth inhibition of breast cancer cell lines by combinations of anti-P185HER2 monoclonal antibody and cytokines.
M. S. Kopreski, A. Lipton, H. Harvey, R. Kumar
1996Anticancer Research26 citations
Semantic Scholar
Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer
A. Manni, A. Boucher, L. Demers, H. Harvey +3 more
1989Breast Cancer Research and Treatment26 citations
Semantic Scholar
Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma.
H. Harvey
1997Cancer25 citations
Semantic Scholar
Aromatase inhibitors in clinical practice: current status and a look to the future.
H. Harvey
1996Seminars in Oncology25 citations
Semantic Scholar
Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.
B. Faltas, A. Zeidan, K. Peters, Avisnata Das +8 more
2011Journal of Clinical Oncology24 citations
Semantic Scholar
Efficacy of the combination of ABT-888 (veliparib) and carboplatin in patients with BRCA-associated breast cancer.
G. Somlo, P. Frankel, T. Luu, Cynthia X. Ma +16 more
201320 citations
Semantic Scholar
Phase II trial of single agent PARP inhibitor ABT-888 (veliparib [vel]) followed by postprogression therapy of vel with carboplatin (carb) in patients (pts) with stage BRCA-associated metastatic breast cancer (MBC): California Cancer Consortium trial PHII-96.
G. Somlo, P. Frankel, T. Luu, Cynthia X. Ma +16 more
201419 citations
Semantic Scholar
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancer.
L. Demers, A. Lipton, H. Harvey, J. Hanagan +2 more
1993Journal of Steroid Biochemistry and Molecular Biology19 citations
Semantic Scholar
A Randomized Trial of Aminoglutethimide ± Estrogen Before Chemotherapy in Advanced Breast Cancer
A. Lipton, R. Santen, H. Harvey, A. Manni +7 more
1987American Journal of Clinical Oncology18 citations
Semantic Scholar
Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma
R. Santen, A. Manni, H. Harvey
2005Breast Cancer Research and Treatment17 citations
Semantic Scholar
Combined chemoradiotherapy for unresectable pancreatic cancer.
Jeffrey L. Martin, H. Harvey, A. Lipton, Ruth Martin
1999American Journal of Clinical Oncology17 citations
Semantic Scholar
Somatostatin analogues in the treatment of breast and prostate cancer.
A. Manni, A. Boucher, L. Demers, H. Harvey +3 more
1990Journal of Steroid Biochemistry and Molecular Biology17 citations
Semantic Scholar
Marked heterogeneity of aromatase activity in human malignant melanoma tissue.
R. J. Santen, S. Santner, H. Harvey, Allan Lipton +4 more
1988European Journal of Cancer and Clinical Oncology17 citations
Semantic Scholar
Maintenance etidronate in the prevention of malignancy-associated hypercalcemia.
Joan H. Schiller, Paul Rasmussen, Al B. Benson, R. Witte +6 more
1987Archives of Internal Medicine15 citations
Semantic Scholar
Phase I study combining tumor necrosis factor with interferon-alpha and interleukin-2.
E. Eskander, H. Harvey, E. Givant, A. Lipton
1997American Journal of Clinical Oncology14 citations
Semantic Scholar
The management of hypercalcemia of malignancy
H. Harvey
1995Supportive Care in Cancer14 citations
Semantic Scholar
Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.
A. Lipton, H. Harvey, L. Witters, S. Kerr +2 more
2004Oncology13 citations
Semantic Scholar
Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma
Neil Belman, E. Bonnem, H. Harvey, A. Lipton
2004Investigational new drugs13 citations
Semantic Scholar
CA‐549: A new tumor marker for patients with advanced breast cancer
L. Demers, H. Harvey, J. Glenn, P. Gaur
198813 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Lipton×23
Invite
A. Lipton — researcher profile on SciRah
L. Demers×10
Invite
L. Demers — researcher profile on SciRah
R. Santen×8
Invite
R. Santen — researcher profile on SciRah
A. Manni×6
Invite
A. Manni — researcher profile on SciRah

×6

Invite

M. Bartholomew — researcher profile on SciRah

Invite

M. Simmonds — researcher profile on SciRah

Invite

K. Leitzel — researcher profile on SciRah

Invite

J. Drabick — researcher profile on SciRah

V. Chinchilli×3

Invite

V. Chinchilli — researcher profile on SciRah

Invite

W. Carney — researcher profile on SciRah

Invite

A. Boucher — researcher profile on SciRah

Invite

G. Somlo — researcher profile on SciRah